Global Information
회사소개 | 문의 | 비교리스트

바이오 원료 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회 및 예측(2021-2026년)

Biotech Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 11월 상품코드 1037177
페이지 정보 영문 142 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 2,299 ₩ 2,989,000 PDF (Single User License)
US $ 3,399 ₩ 4,420,000 PDF (5 User License)
US $ 4,499 ₩ 5,850,000 PDF (Corporate License)


바이오 원료 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회 및 예측(2021-2026년) Biotech Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 11월 페이지 정보 : 영문 142 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 바이오 원료 시장 규모는 2015-2020년간 완만하게 성장했습니다. 2021-2026년간 8.6%의 연평균 복합 성장률(CAGR)로 시장 규모가 확대될 것으로 예상됩니다.

안전하고, 강력한, 첨단이며, 효과적인 화장품에 대한 소비자 선호도 변화가 히알루론산에서부터 콜라겐에 이르기까지 새로운 화장품 처방 개발에 바이오 원료 채용을 촉진하는 주요인 중 하나가 되고 있습니다. 오가닉 친환경 제품 수요가 높아지고 있는 점 또한 하이브리드 스킨케어 제품에 대한 바이오 원료 이용을 촉진하고 있습니다. 시장을 선도하는 기업은 혁신적인 제품을 투입하기 위해서 과학적인 연구에도 투자하고 있습니다. 예를 들면, 차세대 미용 제품을 개발하기 위해서 바이오미메틱스, 3D 바이오프린팅, 식물 조직배양 기술 등에 주목하고 있습니다. 또한 생산 공정에서 발생하는 폐기물을 재활용/살균/폐기함으로써 원재료의 이산화탄소 배출량을 감축하고 있습니다. 이 외에도 바이오 원료는 식음료(F&B) 업계에서 향료(Flavor) 첨가나 효소/유화제 용도를 향상시키기 위해서 인기를 끌고 있습니다. 제약 업계에서는 천연 유래 유효 성분을 배합하기 위해서 이러한 성분 사용이 증가할 것으로 예상됩니다.

세계의 바이오 원료(Biotech Ingredients) 시장에 대해 조사했으며, 업계 동향, 시장 예측, 종류·용도·지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다. 또한 COVID-19의 불확실성을 염두에 두고, 다양한 최종 이용 산업에 대한 팬데믹의 직접적/간접적인 영향을 지속적으로 추적 및 평가하고 있습니다 .

목차

제1장 서문

제2장 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 바이오 원료 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향

제6장 유형별 시장 세분화

  • 효모
  • 조류(Algae)
  • 기타

제7장 용도별 시장 세분화

  • 식품 및 음료
  • 퍼스널케어 용품/화장품
  • 청소 용품
  • 기타

제8장 지역별 시장 세분화

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동 및 아프리카
    • 국가별 시장 세분화

제9장 SWOT 분석

제10장 밸류체인 분석

제11장 Porter의 산업 분석

제12장 가격 분석

제13장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • AbbVie Inc.
    • Advanced Biotech
    • Amyris Inc.
    • Becton Dickinson and Company
    • Bell Flavors & Fragrances Inc.
    • Bruker Corporation
    • Evolva AG
    • Evonik Industries AG
    • GlaxoSmithKline plc.
    • International Flavors & Fragrances Inc.
    • Merck KGaA
    • Sanofi SA
LSH 21.12.03

The global biotech ingredients market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Biotech ingredients are prepared using organisms like algae, yeast or bacteria that undergo deoxyribonucleic acid (DNA) editing to enhance the metabolic process of microbes. They are cost-effective and generate a low environmental impact than ingredients processed using petrochemicals. They act as a sustainable alternative to formulate plant-based extracts, which can counteract oxidative damages and slow down the aging process. Consequently, cosmetics companies worldwide are extensively using biotech ingredients to develop and evaluate the activity of natural active components on the skin.

A considerable shift in consumer preferences towards safe, potent, advanced and ef?cacious cosmetics solutions represents one of the key factors encouraging the adoption of biotech ingredients to produce new cosmetic formulas, ranging from hyaluronic acid to collagen. Additionally, the escalating demand for organic and sustainable products is promoting the utilization of biotech ingredients in hybrid skincare products. The leading market players are also investing in scienti?c research to introduce innovative products. For instance, they are focusing on biomimetics, 3D bioprinting and plant tissue culture technologies to develop next-generation beauty products. In line with this, they are recycling, sterilizing and disposing of the waste generated during the production process, which helps in reducing the carbon footprint of raw materials. Apart from this, biotech ingredients are gaining traction in the food and beverage (F&B) industry for adding flavors and improving enzymes and emulsifiers applications. Furthermore, the usage of these ingredients is anticipated to rise in the pharmaceutical industry to formulate active ingredients from natural sources.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biotech ingredients market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type and application.

Breakup by Type:

  • Yeast
  • Algae
  • Others

Breakup by Application:

  • Food and Beverages
  • Personal Care and Cosmetics
  • Cleaning Products
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Advanced Biotech, Amyris Inc., Becton Dickinson and Company, Bell Flavors & Fragrances Inc., Bruker Corporation, Evolva AG, Evonik Industries AG, GlaxoSmithKline plc., International Flavors & Fragrances Inc., Merck KGaA and Sanofi SA.

Key Questions Answered in This Report:

  • How has the global biotech ingredients market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biotech ingredients market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biotech ingredients market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotech Ingredients Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Yeast
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Algae
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Food and Beverages
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Personal Care and Cosmetics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cleaning Products
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AbbVie Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Advanced Biotech
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Amyris Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Becton Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bell Flavors & Fragrances Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Bruker Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Evolva AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Evonik Industries AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 GlaxoSmithKline plc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 International Flavors & Fragrances Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Merck KGaA
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Sanofi SA
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
Back to Top
전화 문의
F A Q